Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Silva M, Barretta F, Luksch R, Terenziani M, Casanova M, Spreafico F, Meazza C, Podda M, Biassoni V, Schiavello E, Chiaravalli S, Puma N, Bergamaschi L, Gattuso G, Sironi G, Adduci A, Grampa P, Massimino M, Ferrari A. Adolescents with cancer on privacy: Fact-finding survey on the need for confidentiality and space. Tumori 2021;107:452-457. [PMID: 33509050 DOI: 10.1177/0300891620988357] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Number

Cited by Other Article(s)

Critoph DJ, Taylor RM, Spathis A, Duschinsky R, Hatcher H, Clyne E, Kuhn I, Smith LAM. Triadic communication with teenagers and young adults with cancer: a systematic literature review - 'make me feel like I'm not the third person'. BMJ Open 2024;14:e080024. [PMID: 38367963 PMCID: PMC10875529 DOI: 10.1136/bmjopen-2023-080024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Accepted: 02/02/2024] [Indexed: 02/19/2024] Open

Abstract

OBJECTIVES

Clinical communication needs of teenagers and young adults with cancer (TYACs) are increasingly recognised to differ significantly from younger children and older adults. We sought to understand who is present with TYACs, TYACs' experiences of triadic communication and its impact. We generated three research questions to focus this review: (1) Who is present with TYACs in healthcare consultations/communication?, (2) What are TYACs' experiences of communication with the supporter present? and (3) What is the impact of a TYAC's supporter being present in the communication?

DESIGN

Systematic review with narrative synthesis.

DATA SOURCES

The search was conducted across six databases: Medline, CINAHL, Embase, PsycINFO, Web of Science and AMED for all publications up to December 2023.

ELIGIBILITY CRITERIA FOR SELECTING STUDIES

Included papers were empirical research published after 2005; participants had malignant disease, diagnosed aged 13-24 years (for over 50% of participants); the research addressed any area of clinical communication.

DATA EXTRACTION AND SYNTHESIS

Three independent reviewers undertook full-text screening. A review-specific data extraction form was used to record participant characteristics and methods from each included paper and results relevant to the three review questions.

RESULTS

A total of 8480 studies were identified in the search, of which 36 fulfilled the inclusion criteria. We found that mothers were the most common supporter present in clinical communication encounters. TYACs' experiences of triadic communication are paradoxical in nature-the supporter can help or hinder the involvement of the young person in care-related communication. Overall, young people are not included in clinical communication and decisions at their preferred level.

CONCLUSION

Triadic communication in TYACs' care is common, complex and dynamic. Due to the degree of challenge and nuances raised, healthcare professionals need further training on effective triadic communication.

PROSPERO REGISTRATION NUMBER

CRD42022374528.

Collapse

Neylon K, Condren C, Guerin S, Looney K. What Are the Psychosocial Needs of Adolescents and Young Adults with Cancer? A Systematic Review of the Literature. J Adolesc Young Adult Oncol 2023;12:799-820. [PMID: 37130327 DOI: 10.1089/jayao.2022.0130] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/04/2023] Open

Silva M, Guglielmi M, Clerici CA, Massimino M, Ferrari A. Blooming in the rain. Tumori 2023:3008916231163933. [PMID: 36964669 DOI: 10.1177/03008916231163933] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/26/2023]

Nigro O, Sironi G, Ferrari A, Tinè G, Infante G, Barretta F, Silva M, Clerici CA, Chiaravalli S, Schiavello E, Biassoni V, Podda M, Meazza C, Spreafico F, Casanova M, Terenziani M, Luksch R, Massimino M. Managing Care during the COVID-19 Pandemic: The Point of View and Fears of Pediatric Cancer Patients’ Families. Children 2022;9:children9040554. [PMID: 35455598 PMCID: PMC9025749 DOI: 10.3390/children9040554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 02/11/2022] [Revised: 03/14/2022] [Accepted: 04/07/2022] [Indexed: 11/16/2022]

Affiliation(s)

Olga Nigro Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Giovanna Sironi Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Andrea Ferrari Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Gabriele Tinè Clinical Epidemiology and Trial Organization Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (G.T.); (G.I.); (F.B.)
Gabriele Infante Clinical Epidemiology and Trial Organization Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (G.T.); (G.I.); (F.B.)
Francesco Barretta Clinical Epidemiology and Trial Organization Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (G.T.); (G.I.); (F.B.)
Matteo Silva Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Carlo Alfredo Clerici Department of Oncology and Hemato-Oncology, University of Milan, 20100 Milan, Italy; SSD Clinical Psychology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
Stefano Chiaravalli Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Elisabetta Schiavello Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Veronica Biassoni Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Marta Podda Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Cristina Meazza Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Filippo Spreafico Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Michela Casanova Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Monica Terenziani Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Roberto Luksch Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.)
Maura Massimino Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; (O.N.); (G.S.); (A.F.); (M.S.); (S.C.); (E.S.); (V.B.); (M.P.); (C.M.); (F.S.); (M.C.); (M.T.); (R.L.) Correspondence: ; Tel.: +39-022-390-2588

Collapse

Ferrari A, Quarello P, Mascarin M, Luigi Banna G, Toss A, Sironi G, Zecca M, Cinieri S, Alessandro Peccatori F. Italian pediatric and adult oncology communities join forces for a national project dedicated to adolescents and young adults with cancer. Tumori 2021;108:104-110. [PMID: 34841968 DOI: 10.1177/03008916211058790] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]